by George Ciuciureanu | Jun 26, 2025 | Events, Health
Augurex to attend and sponsor Ten Topics in Rheumatology 2025, July 3–4 in London, UK. Showcasing biomarker-based diagnostics: JOINTstat® for rheumatoid arthritis and SPINEstat™, a first-in-class diagnostic for axial spondyloarthritis Vancouver, Canada – June 26, 2025...
by George Ciuciureanu | Jun 16, 2025 | Events, Health
Augurex to sponsor the AS/axSpA Back Summit 2025, hosted by the Canadian Spondyloarthritis Association (CSA) Featuring SPINEstat™, a Health Canada-approved, first-in-class diagnostic blood test for the early and accurate detection of axial spondyloarthritis (axSpA)....
by George Ciuciureanu | Jun 6, 2025 | Events, Health
Augurex to attend BIO 2025, June 16–19, in Boston, MA, the world’s largest biotechnology partnering event. Showcasing biomarker-based diagnostics for rheumatoid arthritis and axial spondyloarthritis, including JOINTstat® and first-in-class SPINEstat™. Vancouver,...
by George Ciuciureanu | Jun 4, 2025 | Events, Health
Augurex to present a poster and share a second accepted abstract at EULAR 2025, taking place June 11–14 in Barcelona. New findings highlight the value of 14-3-3eta autoantibodies in improving early detection of axSpA, including in HLA-B27–negative patients. Vancouver,...
by George Ciuciureanu | Apr 30, 2025 | Events, Health
Augurex to participate in the SPARTAN 2025 Annual Meeting, taking place May 9–10 in Toronto, Canada. Featuring SPINEstat™, a Health Canada-approved, first-in-class blood test for the early diagnosis and monitoring of axial spondyloarthritis (axSpA). Vancouver, Canada...
by George Ciuciureanu | Apr 25, 2025 | Events, Health
Augurex to attend British Society for Rheumatology 2025 Annual Meeting in Manchester, UK Highlighting biomarker-based diagnostic innovations for RA and axSpA Vancouver, Canada – April 25, 2025 – Augurex Life Sciences Corp., a leader in biomarker-based diagnostics for...
